http://www.acc.org/Feed?clinicalTopicID=7477ae68-a2db-444b-a0b2-e21d88347930 Clinical Topic Feed: Cardiac Surgery en /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/PARTNER-2A-P2S3i-Registry The rates of mortality and reintervention at 10 years were higher in patients at intermediate risk who underwent TAVR with the second-generation SAPIEN XT valve than those who underwent surgery in the PARTNER 2A trial, according to an analysis published June 16 in a valvular heart disease focus issue of JACC. 1782399420000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/23/13/25/Genotype-Independently-Predicts-HF-Outcomes In patients with hypertrophic cardiomyopathy (HCM), genotype, peak VO2, log NT-proBNP and LVEF independently predict heart failure (HF) outcomes, and combining these measures identified patients at higher risk of HF-related death or transplant, according to a recent study published in JACC: Heart Failure. 1782228900000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/06/17/16/52/TAVR-vs-SAVR TAVR outcomes differ by sex and vary over time, with women seeing an early benefit with TAVR vs. SAVR that converged by year five and men exhibiting no significant differences across time points, according to a meta-analysis of nine randomized trials published June 10 in JACC: Advances. 1781807400000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/17/17/38/CMS-Proposes-Updates-to-TAVR-National-Coverage-Determination The Centers for Medicare and Medicaid Services (CMS) released a proposed decision memo on the National Coverage Determination (NCD) for TAVR, introducing changes to coverage pathways, evidence development and quality oversight. 1781718060000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Feature-Navigating-Valve-Disease Shared decision-making has become central to the management of valve disease, including tricuspid regurgitation (TR) (see cover story) and severe aortic stenosis (AS). If done correctly, it can help clinicians engage patients and families in meaningful discussions about symptoms, prognosis, treatment burden and personal goals... 1780316280000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Peripheral-Matters-Lower-Extremity-Atherectomy Peripheral artery disease (PAD) affects more than 12 million Americans and is a leading cause of limb loss and cardiovascular mortality. Atherectomy – the mechanical removal of atherosclerotic plaque – has emerged as an important adjunct to balloon angioplasty, stenting and drug delivery systems... 1780316100000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Focus-on-Intervention The wave of coronary and structural heart intervention trials from last year is shifting how interventional cardiologists may approach patient care. Across multiple domains including coronary devices, revascularization strategies, lesion preparation and structural therapies, new data are challenging long-standing assumptions... 1780316040000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1780315620000 Articles and Stories /Latest-in-Cardiology/Articles/2022/01/01/01/01/ACC-Featured-Jobs Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career! 1780305360000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/26/13/15/Evolut-Low-Risk-Trial-Six-Year-Outcomes The Evolut Low Risk trial was a prospective randomized trial that enrolled patients at low surgical risk with severe trileaflet aortic stenosis from 87 international sites between 2016 and 2019. 1779899100000 Articles and Stories